TY - JOUR
T1 - Development of novel rat model for high-fat and high-cholesterol diet-induced steatohepatitis and severe fibrosis progression in SHRSP5/Dmcr
AU - Kitamori, Kazuya
AU - Naito, Hisao
AU - Tamada, Hazuki
AU - Kobayashi, Miya
AU - Miyazawa, Daisuke
AU - Yasui, Yuko
AU - Sonoda, Kunihiro
AU - Tsuchikura, Satoru
AU - Yasui, Naomi
AU - Ikeda, Katsumi
AU - Moriya, Takashi
AU - Yamori, Yukio
AU - Nakajima, Tamie
N1 - Funding Information:
Acknowledgments This work was supported by a Grant-in-Aid for Young Scientists B (20700603) and Scientific Research (23390161) from the Japan Society for the Promotion of Science.
PY - 2012/5
Y1 - 2012/5
N2 - Objectives Patients with nonalcoholic fatty liver disease are increasing worldwide, and preventive measures are an urgent need and primary concern today. Aim This study aimed to develop and clarify the usefulness of the SHRSP5/Dmcr rat, derived from a stroke-prone spontaneously hypertensive rat, as a novel animal model for time-course analysis of steatohepatitis and the severe fibrosis progression often observed in the disease. Methods Ten-week-old male SHRSP5/Dmcr rats were divided into six groups: half were fed a high-fat and highcholesterol- containing diet (HFC diet), and the others the control, stroke-prone (SP) diet for 2, 8, and 14 weeks. Results The HFC diet significantly increased serum transaminase and gamma glutamyl transpeptidase activities, tumor necrosis factor alpha levels, and serum and hepatic total cholesterol levels over time. In contrast, this diet decreased serum albumin, glucose, and adiponectin levels throughout or the later stage of the feeding period, but did not influence serum insulin levels. Histopathologically, the HFC diet increased microvesicular steatosis, and focal or spotty necrosis with lymphocyte infiltrations were observed in the liver at 2 weeks, macrovesicular steatosis, ballooned hepatocytes with Mallory- Denk body formation in some, and multilobular necrosis and fibrosis at 8 weeks. Interestingly, this fibrosis formed a honeycomb network at 14 weeks. These changes are very similar to those observed in patients with non-alcoholic steatohepatitis. Conclusions SHRSP5/Dmcr rats appear to be a useful model for analyzing the time-dependent changes of HFC diet-induced steatohepatitis and fibrosis progression.
AB - Objectives Patients with nonalcoholic fatty liver disease are increasing worldwide, and preventive measures are an urgent need and primary concern today. Aim This study aimed to develop and clarify the usefulness of the SHRSP5/Dmcr rat, derived from a stroke-prone spontaneously hypertensive rat, as a novel animal model for time-course analysis of steatohepatitis and the severe fibrosis progression often observed in the disease. Methods Ten-week-old male SHRSP5/Dmcr rats were divided into six groups: half were fed a high-fat and highcholesterol- containing diet (HFC diet), and the others the control, stroke-prone (SP) diet for 2, 8, and 14 weeks. Results The HFC diet significantly increased serum transaminase and gamma glutamyl transpeptidase activities, tumor necrosis factor alpha levels, and serum and hepatic total cholesterol levels over time. In contrast, this diet decreased serum albumin, glucose, and adiponectin levels throughout or the later stage of the feeding period, but did not influence serum insulin levels. Histopathologically, the HFC diet increased microvesicular steatosis, and focal or spotty necrosis with lymphocyte infiltrations were observed in the liver at 2 weeks, macrovesicular steatosis, ballooned hepatocytes with Mallory- Denk body formation in some, and multilobular necrosis and fibrosis at 8 weeks. Interestingly, this fibrosis formed a honeycomb network at 14 weeks. These changes are very similar to those observed in patients with non-alcoholic steatohepatitis. Conclusions SHRSP5/Dmcr rats appear to be a useful model for analyzing the time-dependent changes of HFC diet-induced steatohepatitis and fibrosis progression.
UR - http://www.scopus.com/inward/record.url?scp=84862891065&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84862891065&partnerID=8YFLogxK
U2 - 10.1007/s12199-011-0235-9
DO - 10.1007/s12199-011-0235-9
M3 - Article
C2 - 21853259
AN - SCOPUS:84862891065
SN - 1342-078X
VL - 17
SP - 173
EP - 182
JO - Environmental Health and Preventive Medicine
JF - Environmental Health and Preventive Medicine
IS - 3
ER -